Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy

Curcumin, when used in a combination regimen in multiple myeloma patients, has comparable progression‐free survival without the adverse effects of steroid‐based combination therapies that is curcumin may be a viable alternative to corticosteroids in combination with an immunomodulatory drug or prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramakrishna, Rajeev, Diamond, Terrence H., Alexander, William, Manoharan, Arumugam, Golombick, Terry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141712/
https://www.ncbi.nlm.nih.gov/pubmed/32274049
http://dx.doi.org/10.1002/ccr3.2735
_version_ 1783519249529044992
author Ramakrishna, Rajeev
Diamond, Terrence H.
Alexander, William
Manoharan, Arumugam
Golombick, Terry
author_facet Ramakrishna, Rajeev
Diamond, Terrence H.
Alexander, William
Manoharan, Arumugam
Golombick, Terry
author_sort Ramakrishna, Rajeev
collection PubMed
description Curcumin, when used in a combination regimen in multiple myeloma patients, has comparable progression‐free survival without the adverse effects of steroid‐based combination therapies that is curcumin may be a viable alternative to corticosteroids in combination with an immunomodulatory drug or proteasome inhibitor.
format Online
Article
Text
id pubmed-7141712
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-71417122020-04-09 Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy Ramakrishna, Rajeev Diamond, Terrence H. Alexander, William Manoharan, Arumugam Golombick, Terry Clin Case Rep Case Reports Curcumin, when used in a combination regimen in multiple myeloma patients, has comparable progression‐free survival without the adverse effects of steroid‐based combination therapies that is curcumin may be a viable alternative to corticosteroids in combination with an immunomodulatory drug or proteasome inhibitor. John Wiley and Sons Inc. 2020-02-25 /pmc/articles/PMC7141712/ /pubmed/32274049 http://dx.doi.org/10.1002/ccr3.2735 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Ramakrishna, Rajeev
Diamond, Terrence H.
Alexander, William
Manoharan, Arumugam
Golombick, Terry
Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy
title Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy
title_full Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy
title_fullStr Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy
title_full_unstemmed Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy
title_short Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy
title_sort use of curcumin in multiple myeloma patients intolerant of steroid therapy
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141712/
https://www.ncbi.nlm.nih.gov/pubmed/32274049
http://dx.doi.org/10.1002/ccr3.2735
work_keys_str_mv AT ramakrishnarajeev useofcurcumininmultiplemyelomapatientsintolerantofsteroidtherapy
AT diamondterrenceh useofcurcumininmultiplemyelomapatientsintolerantofsteroidtherapy
AT alexanderwilliam useofcurcumininmultiplemyelomapatientsintolerantofsteroidtherapy
AT manoharanarumugam useofcurcumininmultiplemyelomapatientsintolerantofsteroidtherapy
AT golombickterry useofcurcumininmultiplemyelomapatientsintolerantofsteroidtherapy

Ejemplares similares